Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
07/2001
07/26/2001WO2000071741A9 Dna encoding a human subunit of the 5-ht3 serotonin receptor
07/26/2001WO2000070341A3 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
07/26/2001WO2000066995A3 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification
07/26/2001WO2000055194A9 Tuberculosis antigens and methods of use therefor
07/26/2001WO2000045169A9 Methods for enhancing binding interactions between members of specific binding pairs
07/26/2001WO2000041566A9 Regulation of endogenous gene expression in cells using zinc finger proteins
07/26/2001WO2000037683A9 HIGH THROUGHPUT ASSAY SYSTEM FOR MONITORING ESTs
07/26/2001WO2000017361A3 Interferon-epsilon
07/26/2001WO2000015178A3 Computer implemented pharmacokinetics method and program
07/26/2001US20010009905 Adipocyte Complement-Related Protein encoded polypeptides, used in therapy and diagnosis, cell proliferation, cell death, energy homestasis; treatment of cancers, obesity, diabetes, heart disease, immunity
07/26/2001US20010009903 Roasting process using far infrared radiation, microorganism fermentation to produce peroxide lipid thereby improving antitumor activity
07/26/2001US20010009900 Breast cancer, increase insulin receptor phosphorylation in Type II diabetics
07/26/2001US20010009774 Comprising molecular adhesive layer chemically adsorbed to surface of solid state element, three dimensional layer of hydrophilic polymer bonded to molecular adhesive layer, bioelement immobilized in layer by adhesive
07/26/2001US20010009772 Transfecting cell with first polynucleotide comprising retroviral genome operably linked to first inducible transcription regulation element wherein retroviral genome is defective for self-replication, second, third polynucleotides
07/26/2001US20010009766 Dna encoding galanin galr3 receptors and uses thereof
07/26/2001US20010009763 Array of a plurality of particles having probes, respectively, fixed thereon, said probes being capable of binding to different target substances to be examined, respectively
07/26/2001US20010009762 Covalently attaching with a prokaryotic enzyme at least one non-radioactively labeled ribonucleotide to the 3' end of said ribonucleic acid, whereby said ribonucleic acid is end-labeled
07/26/2001US20010009761 Methods and oligonucleotides for detecting nucleic acid sequence variations
07/26/2001US20010009760 Reducing background signals in nucleic acid hybridization assays by using an oligonucleotide labelled with a quenchable dipyrrolometheneboron difluoride dye
07/26/2001US20010009757 A closed, sterile continuous flow process by selectively binding a specific cell population to a particle having a selective binding site to form a conjugate; separating by continuous flow centrifuging; sedimentation; immunoaffinity
07/26/2001US20010009667 Method of detecting nucleic acid encoding a retrovirus using polymerase chain reaction (pcr)
07/26/2001DE19963857A1 Primer, insbesondere für Primer-abhängige Nukleinsäure-Syntheseprozesse und Nukleinsäure-Amplifikationsverfahren Primer, particularly for primer-dependent nucleic acid synthesis and nucleic acid amplification processes
07/26/2001DE19962148A1 Detecting cleaning and/or disinfection of surfaces or objects used in the health care and pharmaceutical industries comprises using an applicator with a carrier
07/26/2001DE10001140A1 Oligonukleotide zur Amplifikation und zum Nachweis von bakteriellen Genen für extrazelluläre alkalische Metallopeptidasen (Apr), neutrale Metallopeptidasen (Npr) und Serinpeptidasen (Spr) Oligonucleotides for amplification and detection of bacterial genes for extracellular alkaline metallopeptidases (Apr), neutral metallopeptidases (Npr) and serine peptidases (Prov)
07/26/2001DE10000651A1 Identifying inhibitors and activators of eukaryotic potassium channels, for use as pharmaceuticals, comprises using yeast cells that express heterologous, but no endogenous, potassium channels
07/26/2001CA2479511A1 Compositions and methods for the treatment of tumor
07/26/2001CA2479498A1 Compositions and methods for the treatment of tumor
07/26/2001CA2398839A1 Method and marker for identification of pre-malignancy and malignancy and therapeutic intervention
07/26/2001CA2398808A1 Biocidal molecules, macromolecular targets and methods of production and use
07/26/2001CA2398710A1 Egg specific surface proteins
07/26/2001CA2398695A1 Chondromodulin-i related peptide
07/26/2001CA2398690A1 Barcoded synthetic lethal screening to identify drug targets
07/26/2001CA2398683A1 Rapid determination of gene structure using cdna sequence
07/26/2001CA2398343A1 Virus strains for the oncolytic treatment of cancer
07/26/2001CA2398243A1 Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease
07/26/2001CA2398083A1 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
07/26/2001CA2398078A1 Method and device for detecting temperature-dependent parameters such as association/dissociation parameters and/or the equilibrium constant of complexes that comprise at least two components
07/26/2001CA2398058A1 Gene chip for neonate screening
07/26/2001CA2398010A1 An in vivo screen using chemical inducers of dimerization
07/26/2001CA2397946A1 Lipid metabolism enzymes
07/26/2001CA2397931A1 Swine defective for transmission of porcine endogenous retrovirus and uses thereof
07/26/2001CA2397901A1 Cbp86, a sperm specific protein
07/26/2001CA2397896A1 Human sperm specific lysozyme-like proteins
07/26/2001CA2397883A1 Methods of and apparatus for separating and detecting nucleic acid
07/26/2001CA2397838A1 Sperm specific proteins
07/26/2001CA2397774A1 Jak/stat pathway inhibitors and the uses thereof
07/26/2001CA2397656A1 Integrated support, integrated minute vessels and permeable membrane, and method of making and using the same
07/26/2001CA2397617A1 Novel human nucleic acid molecules and polypeptides encoding cation channels
07/26/2001CA2397611A1 Classification and characterization of tissue through features related to adipose tissue
07/26/2001CA2397603A1 Non-invasive in-vivo tissue classification using near-infrared measurements
07/26/2001CA2397571A1 Apoptin-associating protein
07/26/2001CA2397324A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom
07/26/2001CA2397205A1 Antisense modulation of macrophage migration inhibitory factor expression
07/26/2001CA2397059A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
07/26/2001CA2396935A1 Phosphatases
07/26/2001CA2396810A1 Sensitive, multiplexed diagnostic assays for protein analysis
07/26/2001CA2395770A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides
07/26/2001CA2395749A1 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides
07/26/2001CA2395736A1 Novel nucleic acids and polypeptides
07/26/2001CA2395731A1 Methods and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides
07/26/2001CA2395054A1 Human polynucleotides, polypeptides, and antibodies
07/26/2001CA2394753A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
07/26/2001CA2365610A1 Compositions and methods for the treatment of tumor
07/26/2001CA2332208A1 Pharmacophore models for, methods of screening for, and identification of the cytochrome p-450 inhibitory potency of neurokinin-1 receptor antagonists
07/25/2001EP1118860A1 Methods for selecting and producing T cell peptide epitopes and vaccines incorporating said selected epitopes
07/25/2001EP1118859A2 A test device for a multi-items test and the method for producing the same as well as measuring instrument for the test device
07/25/2001EP1118680A1 Method for the diagnosis of polymorphisms in the human PDH E1alpha gene
07/25/2001EP1118679A1 Method for diagnosing polymorphisms in the human PDH E2 gene
07/25/2001EP1118678A1 Method for diagnosing polymorphisms in the human PDH E1 beta gene
07/25/2001EP1118677A1 Oligonucleotides useful in identifying fungicide resistant plant pathogenic fungi
07/25/2001EP1118676A2 Cell isolation method
07/25/2001EP1118675A2 Biosensor
07/25/2001EP1118666A2 Nucleotide sequences coding for the Corynebacterium glutamicum ptsH gene
07/25/2001EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides
07/25/2001EP1118661A1 T cell receptor libraries
07/25/2001EP1118658A1 METHOD FOR PREPARING HIGH PERFORMANCE RecA-LIKE RECOMBINASE/SINGLE-STRANDED NUCLEIC ACID PROBE COMPLEX AND UTILIZATION THEREOF
07/25/2001EP1118618A1 Monitor protein for measuring phosphorylation of protein
07/25/2001EP1118001A1 Method to determine a predisposition to leptin treatment
07/25/2001EP1117999A1 Characterising polypeptides through cleavage and mass spectrometry
07/25/2001EP1117996A2 Method and device for producing and/or analyzing biochemical reaction supporting materials
07/25/2001EP1117991A1 Conductive organic sensors, arrays and methods of use
07/25/2001EP1117985A1 Method for optical excitation of fluorophore marked dna and rna
07/25/2001EP1117843A1 An in vitro activity assay for human hepatitis b virus - (hbv) dna polymerase, and its use for screening for inhibitors of hbv dna polymerase
07/25/2001EP1117842A1 Methods for selecting prostate cancer treatments and treating prostate cancer
07/25/2001EP1117841A1 Method for identifying compounds affecting rna/rna binding protein interactions
07/25/2001EP1117840A1 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant gpiiia and/or variant gpiib allele
07/25/2001EP1117839A1 Multi-loci genomic analysis by a method of improved cycle sequencing
07/25/2001EP1117838A1 A method for analyzing polynucleotides
07/25/2001EP1117837A2 Methods and compositions for the diagnosis and therapy of prostate cancer
07/25/2001EP1117836A2 Expressionanalysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
07/25/2001EP1117834A1 Multiplex genotyping using fluorescent hybridization probes
07/25/2001EP1117833A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers
07/25/2001EP1117832A1 Detection of nucleic acid polymorphism
07/25/2001EP1117831A1 Method for dna- or rna-sequencing
07/25/2001EP1117830A1 Method for determining transcription factor activity and its technical uses
07/25/2001EP1117829A1 Susceptibility locus for osteoarthritis
07/25/2001EP1117828A1 Susceptibility locus for osteoarthritis
07/25/2001EP1117827A1 Methods of nucleic acid amplification and sequencing
07/25/2001EP1117826A1 Oligonucleotide primers that destabilize non-specific duplex formation and uses thereof
07/25/2001EP1117825A1 Method for detecting atp